论文信息 - A Novel CDK4/6 and PARP Dual Inhibitor ZC-22 Effectively Suppresses Tumor Growth and Improves the Response to Cisplatin Treatment in Breast and Ovarian Cancer - 字舞流文

A Novel CDK4/6 and PARP Dual Inhibitor ZC-22 Effectively Suppresses Tumor Growth and Improves the Response to Cisplatin Treatment in Breast and Ovarian Cancer

Yan Fan | R. Xiang | Shuang Yang | Yanan Chen | P. Sun | Zhi Huang | Antao Chang | Qiong Wang | Jianjun Li | Yufan Wei | Yingxue Lin | Xing-yu Lv | Chenchen Tian | Peiqing Sun